Under fire for equine fatalities, racing’s leadership is flailing for responses — while ignoring the almost-good story it could be telling.
The Racing Medication and Testing Consortium (RMTC) has proposed a new rule limiting bisphosphonate use in young horses, as well as taking action on NSAIDs.
Dr. Mary Scollay, most recently equine medical director for the Kentucky Horse Racing Commission, will lead the Racing Medication and Testing Consortium.
The Racing Medication and Testing Consortium (RMTC) has made the University of Florida’s racing lab the 10th in the country to earn full accreditation.
National Thoroughbred Racing Association (NTRA) and Racing Medication and Testing Consortium (RMTC) are teaming up to hold a June conference for racetrack vets.
The RMTC medication group has given interim accreditation to a new lab and issued guidelines to states and horsemen on dealing with glaucine.
Two national racing organizations have come together to promote best practices in test barn management and chain of custody of drug samples.
With its moves in late July, the Pennsylvania Racing Commission made the state the 10th to adopt all tenets of the national uniform medication program.
In response to recent concerns raised by trainer Graham Motion, suspended after a Robaxin positive, the RMTC issued a statement defending its regulations.
Indiana’s revelation that one of racing’s most widely used testing labs missed seven positives, including a Class 1, demands action by the states.
